GIMBE - News Cliniche - Pagina 14

Home

News Cliniche - Pagina 14

ONLINE IL SITO GIMBE SULL'EMERGENZA COVID-19

News Cliniche

GIMBE: Eventi, progetti, pubblicazioni e altre attività istituzionali della Fondazione GIMBE
Metodologiche: articoli pertinenti le aree del know-how GIMBE, pubblicati nei top-six journals*
Cliniche: articoli di ricerca clinica primaria e secondaria pubblicati nei top-six journals*
Sanità: notizie dalla sanità italiana
Eventi: congressi, conferenze, workshop nazionali e internazionali relativi alle aree del know-how GIMBE

*N Engl J Med, Lancet, Ann Intern Med, JAMA, BMJ, PLos Med

30 agosto 2014

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980—2013: a systematic analysis for the Global Burden of Disease Study 2013

Lancet 2014;384:766-781

Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study

Lancet 2014;384:747-754

Percutaneous fixation with Kirschner wires versus volar locking plate fixation in adults with dorsally displaced fracture of distal radius: randomised controlled trial

BMJ 2014;349:g4807

Associations between active commuting, body fat, and body mass index: population based, cross sectional study in the United Kingdom

BMJ 2014;349:g4887

Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study

BMJ 2014;349:g4930

28 agosto 2014

Long-Term Colorectal-Cancer Mortality after Adenoma Removal

N Engl J Med 2014;371:799-807

Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries

N Engl J Med 2014;371:818-827

27 agosto 2014

Effect of Self-monitoring and Medication Self-titration on Systolic Blood Pressure in Hypertensive Patients at High Risk of Cardiovascular Disease. The TASMIN-SR Randomized Clinical Trial

JAMA. 2014;312:799-808.

Collaborative Care for Adolescents With Depression in Primary Care. A Randomized Clinical Trial

JAMA 2014;312:809-816

23 agosto 2014

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Lancet 2014;384:665-673

12

13

14

15

16

Pagina aggiornata il 05/05/2025